Tularik Inc. (TLRK) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who started this subject	11/21/2002 4:48:21 PM
From: scaram(o)uche	Read Replies (1) of 598

CXCR3 ANTAGONISTS Patent Number: Publication date: 2002-10-24 Inventor(s): JOHNSON MICHAEL G (US); HUANG ALAN XI (US); LIU JIWEN (US); LI AN-RONG (US); MARCUS ANDREW P (US); MEDINA JULIO C (US); ZHU LIUSHENG (US) Applicant(s): JOHNSON MICHAEL G (US); HUANG ALAN XI (US); LIU JIWEN (US); TULARIK INC (US); LI AN-RONG (US); MARCUS ANDREW P (US); MEDINA JULIO C (US); ZHU LIUSHENG (US) Requested Patent: WO02083143 Application Number: WO2001US47850 20011211 Priority Number(s): US20000255241P 20001211; US20010296499P 20010606 (no link yet, no abstract yet)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next